News about Drug Discovery & Development

Luye Pharma Gets US FDA Approval of ERZOFRI Extended-Release Injectable Suspension

Luye Pharma Group has announced that the US Food and Drug Administration (FDA) has approved the company's ERZOFRI (paliperidone palmitate) extended-release injectable suspension, for treating schizophrenia in adults and for treating schizoaffective disorder in adults as monotherapy and as an adjunct to mood stabilizers or antidepressants.

Drug Discovery & Development | 30/07/2024 | By Aishwarya |  690

Innovent and WeComput to Accelerate AI-Driven Drug Discovery and Development

Innovent Biologics, Inc. has forged a strategic partnership with WeComput to jointly advance the construction and improvement of Innovent Biologics' Artificial Intelligence for Drug Discovery platform.

Drug Discovery & Development | 26/07/2024 | By Aishwarya |  531

Sun Pharma Gets US FDA Approval for LEQSELVI for Treatment of Severe Alopecia Areata

Sun Pharmaceutical Industries Ltd. has announced that the US Food and Drug Administration (FDA) has approved LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata.

Drug Discovery & Development | 26/07/2024 | By Aishwarya |  1099

Lupin and Huons to Commercialize Cyclosporine Ophthalmic Nanoemulsion in Mexico

Lupin has signed a license and supply deal with Huons Co. Ltd. for the registration and marketing of Cyclosporine Ophthalmic Nanoemulsion, a 0.4mL Single-use Vial, in Mexico.

Drug Discovery & Development | 24/07/2024 | By Aishwarya |  524

Rona Therapeutics Secures USD 35 Million in Series A+ Financing

Rona Therapeutics has received USD 35 million in Series A+ financing round.

Drug Discovery & Development | 22/07/2024 | By Aishwarya |  502

Glenmark Gets ANDA Approval for Topiramate Capsules

Glenmark Pharmaceuticals Ltd. has been granted final approval by the United States Food and Drug Administration (US FDA) for Topiramate Capsules USP, 15 mg and 25 mg.

Drug Discovery & Development | 22/07/2024 | By Aishwarya |  516

Mankind Pharma Signs License Deal with Takeda to Commercialise Acidity Drug in India

Mankind Pharma has signed a non-exclusive patent licence agreement with Takeda Pharmaceuticals for commercialising acidity drug Vonoprazan in the Indian market.

Drug Discovery & Development | 22/07/2024 | By Aishwarya |  1029

Lupin Gets Tentative Approval from US FDA for RLD Sutab

Lupin has secured tentative approval from US FDA for its Abbreviated New Drug Application for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets, 1.479 g/0.225 g/0.188 g, to market a generic equivalent of Sutab Tablets, 1.479 g/0.225 g/0.188 g, of Braintree Laboratories Inc.

Drug Discovery & Development | 18/07/2024 | By Aishwarya |  470

Nona Biosciences Signs Partnership Deal with Alaya.bio to Advance CAR-T Cell Therapy

Nona Biosciences has entered into a collaboration agreement with Alaya. bio to precisely target and reprogram cells in situ and thus to significantly simplify the way CAR-T cell therapies in particular are being developed, manufactured and administered.

Drug Discovery & Development | 15/07/2024 | By Aishwarya |  538

Dr. Reddy's Laboratories Launches Muslaxin in Russia

Dr. Reddy's Russia arm, part of the global pharmaceutical company Dr. Reddy’s Laboratories, has introduced Muslaxin (INN Ibuprofen 400 mg + Chlorzoxazone 500 mg), the first combination drug of NSAID and muscle relaxant that does not have generics in the Russian Federation.

Drug Discovery & Development | 12/07/2024 | By Aishwarya |  1620